1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Palo Alto Networks agreed to acquire observability platform Chronosphere for a total consideration of $3.35 billion, paid in cash and replacement equity awards, subject to adjustments and closing conditions including regulatory approvals. In its fiscal first quarter ended October 31, 2025, revenue grew 16% to $2.5 billion, while GAAP net income fell to $334 million from $351 million. The board also extended a $1 billion share repurchase authorization to December 31, 2026.
Chronosphere acquisition: $3.35 billion total consideration, expected to close in the second half of fiscal 2026
Fiscal Q1 2026: revenue up 16% to $2.5 billion; GAAP net income $334 million, or $0.47 per diluted share, versus $351 million, or $0.49, a year earlier
Non-GAAP net income $662 million, or $0.93 per diluted share, versus $545 million, or $0.78, a year earlier
Board approved extending the $1 billion buyback authorization to December 31, 2026; about 697 million shares outstanding as of November 11, 2025
Universal Technical Institute reported fiscal 2025 revenue of $835.6 million, up 14.0%, and net income of $63.0 million, up 50.0%, with diluted EPS of $1.13 versus $0.75. For fiscal 2026 it guided to net income of $40 million to $45 million and diluted EPS of $0.71 to $0.80, both down 33% at the midpoint, and it said planned growth investments will temporarily moderate margins.
FY2025 revenue $835.6 million, up 14.0%; net income $63.0 million, up 50.0%; diluted EPS $1.13 versus $0.75
Q4 FY2025 revenue $222.4 million, up 13.3%; Q4 net income $18.8 million, flat versus $18.8 million; Q4 adjusted EBITDA $36.8 million, down 1.4%
FY2026 guidance: revenue $905 million to $915 million; net income $40 million to $45 million; adjusted EBITDA $114 million to $119 million versus $126.5 million in FY2025
Company expects to open at least two and up to five campuses and launch about 20 new programs annually, pending regulatory approval
TJX reported third-quarter fiscal 2026 net sales of $15.1 billion, up 7%, and diluted earnings per share of $1.28, up 12% from $1.14 a year earlier. The company raised its full-year fiscal 2026 guidance for comparable sales, pretax profit margin and diluted EPS, and expects to repurchase about $2.5 billion of stock in the fiscal year.
Q3 consolidated comparable sales rose 5%, and pretax profit margin was 12.7%, up from 12.3% a year earlier.
Full-year fiscal 2026 diluted EPS outlook raised to $4.63 to $4.66, a 9% increase over the prior year's $4.26.
Returned $1.1 billion to shareholders in Q3 through $594 million of buybacks and $472 million of dividends.
Q4 fiscal 2026 guidance unchanged: comparable sales up 2% to 3% and diluted EPS of $1.33 to $1.36.
Williams-Sonoma reported third-quarter 2025 results with net revenues of $1.88 billion, comparable brand revenue up 4.0%, and diluted EPS of $1.96, up from $1.87 a year earlier. The company raised its fiscal 2025 operating margin guidance to 17.8% to 18.1% and approved a new $1 billion stock repurchase authorization, which takes effect once the current program is used up.
Q3 net revenues of $1.88 billion; comparable brand revenue up 4.0%, versus a decline of 2.9% in the prior-year quarter
Q3 operating margin of 17.0% and diluted EPS of $1.96, compared with $1.87 a year earlier
Fiscal 2025 operating margin outlook raised to 17.8% to 18.1%; comparable brand revenue growth of 2% to 5% reiterated
As of November 2, 2025, $637 million remained under the September 2024 buyback; a new $1 billion authorization was approved in November 2025
Lowe's reported third-quarter 2025 sales of $20.8 billion, up from $20.2 billion a year earlier, but diluted EPS fell to $2.88 from $2.99. Adjusted diluted EPS rose 5.9% to $3.06 after excluding $129 million in acquisition-related expenses. The company raised its full-year sales outlook to $86.0 billion but lowered its comparable sales and adjusted operating margin outlook, so the update is mixed for shareholders.
Net earnings were $1.6 billion ($1,616 million) versus $1.7 billion ($1,695 million) in the prior-year quarter.
Comparable sales rose 0.4%, with online sales up 11.4%.
Full-year comparable sales are now expected to be flat, previously flat to up 1%; adjusted operating margin is now 12.1%, previously 12.2% to 12.3%.
Full-year adjusted diluted EPS is now approximately $12.25, previously $12.20 to $12.45.
Gilead Sciences disclosed that Deborah H. Telman will no longer serve as Executive Vice President, Corporate Affairs and General Counsel effective December 5, 2025, with her employment ending later in the month. The filing does not give a reason for the departure or name a successor, so shareholders have no information yet on how the change will affect the company's legal and corporate affairs functions.
Deborah H. Telman leaves the role of Executive Vice President, Corporate Affairs and General Counsel effective December 5, 2025.
Her employment with the company will terminate later in November 2025, according to the filing.
The filing does not name a successor or state the reason for the departure.
Griffon reported fiscal 2025 revenue of $2.5 billion, down 4% from the prior year, and net income of $51.1 million ($1.09 per share), down from $209.9 million ($4.23 per share). Results included a $217.2 million net-of-tax charge for third-quarter goodwill and intangible asset impairments in the Consumer and Professional Products segment, while adjusted net income rose to $263.6 million ($5.65 per share). The company also announced a 22% increase in its regular quarterly dividend to $0.22 per share.
Fiscal 2025 revenue was $2.5 billion, down 4% from $2.6 billion; fourth-quarter revenue was $662.2 million, up from $659.7 million.
Fourth-quarter net income was $43.6 million ($0.95 per share), down from $62.5 million ($1.29 per share); adjusted net income was $70.9 million ($1.54 per share) versus $70.9 million ($1.47 per share).
Free cash flow was $323.0 million in fiscal 2025, and leverage fell to 2.4x from 2.6x; the company repurchased 1.9 million shares for $134.7 million.
For fiscal 2026, Griffon expects revenue of $2.5 billion and adjusted EBITDA of $580 million to $600 million.
Penske Automotive Group said a wholly owned subsidiary completed the purchase of four franchised dealerships on November 19, 2025: Longo Toyota and Longo Lexus in El Monte, California, Lexus Stevens Creek in California, and Longo Toyota of Prosper in Texas. The aggregate purchase price is $519,423,000, subject to post-closing adjustments, and the seller is partly owned by entities tied to Chair and CEO Roger S. Penske's family, making this a related-party transaction reviewed by an independent special committee.
Aggregate purchase price of $519,423,000, including $47,673,000 estimated net worth of Penske Motor Group, LLC as of closing, subject to post-closing adjustments
Cash payment of $363,596,100 and $155,826,900 under a 4.5% unsecured senior subordinated promissory note with a three-year term, guaranteed by the company
Press release says the dealerships are expected to add $1.5 billion in estimated annualized revenue and retailed over 28,000 new and used units in 2024
Seller's holding company is 69.35% owned by GWood, an affiliate of Greg Penske, Vice Chair of the Board; the Board's approval was subject to a special committee recommendation
Dycom Industries agreed on November 18, 2025 to acquire Power Solutions, LLC from Project Eastern Shore, LLC for a base price of $1.95 billion, subject to post-closing adjustments. The stock portion is 1,011,069 Dycom shares valued at $292.5 million, and the rest is paid in cash, backed by new debt commitments. Shareholders should note the new share issuance and the added borrowing, and that closing depends on regulatory waiting periods and other conditions.
Base price of $1.95 billion, with stock of 1,011,069 shares valued at $292,500,000 and the remainder in cash
Debt commitments include a $1,000 million term loan A, a $700 million 364-day bridge loan and a $445 million term loan A backstop
Closing is not required before December 22, 2025, and the agreement has an outside date of May 18, 2026
Closing is subject to Hart-Scott-Rodino waiting period expiration and other customary conditions
Valvoline reported fourth-quarter and fiscal 2025 results, with Q4 net revenues up 4% to $453.8 million but reported diluted EPS down 71% to $0.20. The company said it expects to close the $593 million Breeze Autocare acquisition on December 1, 2025, funded by a new $740 million Term Loan B, and gave fiscal 2026 adjusted EPS guidance of $1.60 to $1.70.
Q4 net revenues $453.8 million, up 4%; system-wide same-store sales up 6.0%
Q4 income from continuing operations $25.6 million, down 71%; adjusted EPS $0.45, down 2%
Fiscal 2026 outlook includes Breeze: net revenues $2.0 to $2.1 billion, adjusted EBITDA $525 to $550 million, adjusted EPS $1.60 to $1.70
Breeze deal: $593 million net purchase price, closing planned December 1, 2025; Investor Update scheduled December 11, 2025
Dycom Industries reported fiscal 2026 third-quarter results for the quarter ended October 25, 2025, with contract revenues up 14.1% to $1.452 billion and GAAP net income up to $106.4 million, or $3.63 per diluted share, from $69.8 million, or $2.37, a year earlier. The company raised the midpoint of its fiscal 2026 revenue outlook to a range of $5.350 billion to $5.425 billion and gave fourth-quarter guidance for contract revenues of $1.26 billion to $1.34 billion and diluted EPS of $1.30 to $1.65.
Q3 contract revenues were $1.452 billion, up 14.1%; organic revenue growth was 7.2%
GAAP diluted EPS was $3.63 versus $2.37 a year earlier; net income was $106.4 million versus $69.8 million
Fiscal 2026 contract revenue outlook is $5.350 billion to $5.425 billion, with the midpoint raised
Fourth-quarter fiscal 2026 guidance (quarter ending January 31, 2026): diluted EPS of $1.30 to $1.65
Alkermes amended its agreement to acquire Avadel Pharmaceuticals, raising the cash payment from $18.50 to $21.00 per Avadel share, with the $1.50 contingent value right unchanged. To fund the cash payment, Alkermes entered an amended bridge term loan of up to $1.5 billion that carries variable-rate interest and covenants, and Avadel's board said Lundbeck's competing proposal no longer qualifies as superior. Shareholders face a higher acquisition price and more debt, with closing still expected in the first quarter of 2026.
Cash consideration raised from $18.50 to $21.00 per Avadel share; CVR of up to $1.50 per share unchanged
Total consideration up to $22.50 per share, valuing Avadel at up to approximately $2.37 billion if the milestone payment is made
Bridge loan of up to $1.5 billion with JPMorgan Chase, maturing 364 days after funding; interest at Term SOFR plus 3.00% or base rate plus 2.00%
Avadel board determined Lundbeck's proposal no longer a Company Superior Proposal; closing expected in the first quarter of 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.